expert reaction to two studies looking at AstraZeneca’s GLP 1 pill, elecoglipron, for reducing weight and lowering blood-sugar in adults with and without type 2 diabetes (opens in new tab)

Two studies published in The Lancet look at AstraZeneca’s GLP-1 pill elecoglipron for weight loss and lowering blood-sugar in adults with and without type 2 diabetes.